MAPK8 and inflammatory bowel disease: Our study showed that administration of ivermectin at 5 mg/kg alleviated the severity of IBD, including reducing colonic mucosal inflammation and inflammatory cytokine concentrations, as well as decreasing the expression of phosphorylated ERK, JNK and p38.